Clinical Trial Update: Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients

View source ↗

Summary

A Pfizer-sponsored observational registry study in familial adenomatous polyposis comparing celecoxib-treated patients to controls; the study was terminated and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Adenomatous Polyposis

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: Pfizer | Conditions: Familial Adenomatous Polyposis (FAP) | Status: TERMINATED | Results posted: 2010-03-04